International Journal of Rheumatic Diseases · 2014 · 51 citations · 8 references
MedicineImmunologyPharmacotherapyImmunopathologyInflammationRheumatologyAutoimmune DiseasesEdemaEosinophilic DisordersImmunosuppressionInflammatory Skin DiseasesInflammatory Skin DisordersEosinophilic DermatosesEosinophilic Disease TherapyEosinophilic Skin DisordersImmunosuppressive Drug TherapyRecurrenceRecurrence Rate AnalysisSystemic Immunosuppressive TherapyTriggers
AIM: To describe our experience with 16 patients with eosinophilic fasciitis (EF) treated in our clinic over 14 years. METHODS: We retrospectively reviewed the charts of all patients with biopsy-proven EF. We collected data regarding demographics, clinical presentations, possible triggers, labs, imaging, treatment and response to therapy on follow-up. RESULTS: Eight women and eight men with a mean age of 52 years were included in the study. Three patients related the onset to prior strenuous exercise and one was exposed to vibratory machinery. Fourteen patients had a gradual onset and presented with induration of the skin. Two other patients presented with acute-onset and significant edema and weight gain. All patients required immunosuppressive therapy. Methotrexate (MTX) was used in all of our patients. The rate of complete remission was ~60%. Although the recurrence rate after stopping MTX was 70%, these patients responded well to re-treatment with MTX. CONCLUSION: We believe that MTX represents an effective treatment option for EF. The rarity of this disease would make a double-blind controlled trial study difficult to perform.
8
Eosinophilic fasciitis leading to painless contractures
Peter Huppke, Bernd Wilken, Knut Brockmann et al. · European Journal of Pediatrics · 2002 · 32 citations
Medicine, Immunology, Pathology +5